- Home
- PFE
PFE
Pfizer Inc.
as 05-09-2025 4:00pm EST
| Founded: | 1849 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $30.36 | AVG Volume (30 days): | 48.9M |
| Analyst Decision: | Hold | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $20.92 - $31.54 | Next Earning Date: | 04-29-2025 |
| Revenue: | $62,464,000,000 | Revenue Growth: | 13.80% |
| Revenue Growth (this year): | -0.1% | Revenue Growth (next year): | -0.20% |
Stock Insider Trading Activity of Pfizer Inc. (PFE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DAMICO JENNIFER B. | PFE | SVP & Controller | Feb 27 '25 | Sell | $25.93 | 2,500 | $64,825.00 | 11,850 | |
| BLAYLOCK RONALD E | PFE | Director | Feb 13 '25 | Buy | $25.65 | 19,457 | $499,072.05 | 27,707 |
Latest Pfizer Inc. News
PFE Breaking Stock News: Dive into PFE Ticker-Specific Updates for Smart Investing
Insider Monkey
14 hours ago
Was Jim Cramer Right About Pfizer (PFE)?
Zacks
15 hours ago
5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio
Benzinga
a day ago
If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?
Zacks
a day ago
A Look at Pharma ETFs After Strong Q1 Earnings
Zacks
2 days ago
Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?
Motley Fool
2 days ago
Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks
Pharma Voice
2 days ago
Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications
Benzinga
2 days ago
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
Compare PFE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PFE Pfizer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.